id: scotus_fda_alliance_hippocratic_medicine
title: 'SCOTUS: No standing in challenge to mifepristone changes (FDA v. AHM)'
date: '2024-06-13'
summary: The Supreme Court unanimously held the plaintiffs lacked Article III standing to challenge FDA's
  2016/2021 actions on mifepristone, leaving the agency's changes in place.
location: Washington, DC
actors:
- Supreme Court of the United States
- Food and Drug Administration
tags:
- administrative-law
- courts
- standing
citations:
- https://www.supremecourt.gov/opinions/23pdf/23-235_n7ip.pdf
- https://www.scotusblog.com/cases/case-files/food-and-drug-administration-v-alliance-for-hippocratic-medicine-2/
notes: ''
